Page last updated: 2024-08-24

3-iodobenzylguanidine and Respiratory Distress Syndrome

3-iodobenzylguanidine has been researched along with Respiratory Distress Syndrome in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Damon, L; Dubois, S; Fitzgerald, P; Goldsby, R; Hawkins, R; Hollinger, F; Matthay, KK; Pampaloni, M; Porzig, A	1
Calcagni, ML; Franceschini, R; Fuso, L; Giordano, A; Pistelli, R; Rossi, B; Rufini, V; Troncone, L; Valente, S	1

Other Studies

2 other study(ies) available for 3-iodobenzylguanidine and Respiratory Distress Syndrome

Article	Year
Proteinuria in metastatic pheochromocytoma is associated with an increased risk of Acute Respiratory Distress Syndrome, spontaneously or after therapy with 131I-meta-iodobenzylguanidine (131I-MIBG). Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 2012, Volume: 44, Issue:7 Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Antineoplastic Agents; Child; Compassionate Use Trials; Fatal Outcome; Female; Humans; Male; Metanephrine; Middle Aged; Pheochromocytoma; Proteinuria; Radiography, Thoracic; Radionuclide Imaging; Respiratory Distress Syndrome; Retrospective Studies; Risk Factors; Young Adult	2012
Use of metaiodobenzylguanidine (MIBG) in pneumology. The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), 1995, Volume: 39, Issue:4 Suppl 1 Topics: 3-Iodobenzylguanidine; Adrenergic Fibers; Adult; Aerosols; Animals; Biomarkers; Bronchi; Chromatography; Drug-Related Side Effects and Adverse Reactions; Endothelium, Vascular; Feasibility Studies; Humans; Injections, Intravenous; Iodine Radioisotopes; Iodobenzenes; Lung; Lung Diseases; Metabolic Clearance Rate; Nerve Endings; Norepinephrine; Pulmonary Fibrosis; Radionuclide Imaging; Radiopharmaceuticals; Respiratory Distress Syndrome; Technetium Tc 99m Pentetate	1995

Article

Year

Proteinuria in metastatic pheochromocytoma is associated with an increased risk of Acute Respiratory Distress Syndrome, spontaneously or after therapy with 131I-meta-iodobenzylguanidine (131I-MIBG).

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 2012, Volume: 44, Issue:7

Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Antineoplastic Agents; Child; Compassionate Use Trials; Fatal Outcome; Female; Humans; Male; Metanephrine; Middle Aged; Pheochromocytoma; Proteinuria; Radiography, Thoracic; Radionuclide Imaging; Respiratory Distress Syndrome; Retrospective Studies; Risk Factors; Young Adult

2012

Use of metaiodobenzylguanidine (MIBG) in pneumology.

The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), 1995, Volume: 39, Issue:4 Suppl 1

Topics: 3-Iodobenzylguanidine; Adrenergic Fibers; Adult; Aerosols; Animals; Biomarkers; Bronchi; Chromatography; Drug-Related Side Effects and Adverse Reactions; Endothelium, Vascular; Feasibility Studies; Humans; Injections, Intravenous; Iodine Radioisotopes; Iodobenzenes; Lung; Lung Diseases; Metabolic Clearance Rate; Nerve Endings; Norepinephrine; Pulmonary Fibrosis; Radionuclide Imaging; Radiopharmaceuticals; Respiratory Distress Syndrome; Technetium Tc 99m Pentetate

1995